The following is a summary of remarks by Imunon’s President and CEO Stacy Lindborg, PhD. on the second quarter 2025 financial results conference call, provided for Shareholders unable to join the call ...

Several years ago, Heinz-Josef Lenz, a professor of medicine and cancer biology at the Keck School of Medicine of USC and the ...

Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), ...

Real Housewives of Dallas star D’Andra Simmons announced July 29 that she has been diagnosed with breast cancer, explaining ...

He had prostate cancer and lost his wife Jan to ovarian cancer nearly 12 years ago. LEARN MORE | Sinclair Cares: Help Drive Out Cancer Steve and Jan spent a lot of time driving to appointments.

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Accurate removal of tumors is the most critical aspect of cancer surgery, yet it remains a significant challenge in clinical practice. In breast cancer, for example, the positive margin rate ...

Key Takeaways A young woman survived removal of a 40-pound tumor to become a June bride last monthThe woman flatlined six times during an early attempt to remove the tumorA 14-hour procedure at ...

A young woman became a June bride months after surviving complex surgery to remove a 40-pound tumor from her body, Cedars-Sinai doctors report.

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, offering a promising adjunct to traditional treatments.

This new article publication from Acta Pharmaceutica Sinica B, discusses how a psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis.